Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy

Journal of Clinical Virology

Volumn 54, Issue 2, 2012, Pages 141-146

  Garbuglia, Anna Rosa ^a   Piselli, Pierluca ^a   Lapa, Daniele ^a   Sias, Catia ^a   Del Nonno, Franca ^a   Baiocchini, Andrea ^a   Cimaglia, Claudia ^a   Agresta, Alessandro ^a   Capobianchi, Maria Rosaria ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Cervical lesions; H SIL; HIV; HPV multiple infection; HPV prevalence

Indexed keywords

ANTIVIRUS AGENT; VIRUS DNA;

ADULT; ARTICLE; CARCINOGENESIS; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; ITALY; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; OBSERVATIONAL STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS REPLICATION;

ADULT; CERVIX UTERI; COINFECTION; DNA PRIMERS; DNA, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84860316667     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.02.013     Document Type: Article

References (36)

1. Rijkaart D.C., Berkhof J., Rozendaal L., van Kemenade F.J., Bulkmans N.W., Heideman D.A., et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012, 13:78-88.
2. Levi J.E., Kleter B., Quint W.G., Fink M.C., Canto C.L., Matsubara R., et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV types in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002, 40:3341-3345.
3. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., Wright T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997, 337:1343-1349.
4. Chaturvedi A.K., Myers L., Hammons A.F., Clark R.A., Dunlap K., Kissinger P.J., et al. Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections. Cancer Epidemiol Biomarkers Prev 2005, 14:2439-2445.
5. Vaccarella S., Franceschi S., Herrero R., Schiffman M., Rodriguez A.C., Hildesheim A., et al. Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica. J Infect Dis 2011, 204:385-390.
6. Qu W., Jiang G., Cruz Y., Chang C.J., Ho G.Y., Klein R.S., et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997, 35:1304-1310.
7. Minosse C., Garbuglia A.R., Lapa D., Sias C., Zaniratti M.S., Capobianchi M.R. Genetic variability in E6, E7 and L1 protein of HPV81 from HIV-1 positive women in Italy. New Microbiol 2010, 33:25-35.
8. Cappiello G., Garbuglia A.R., Salvi R., Rezza G., Giuliani M., Pezzotti P., et al. HIV infection increases the risk of squamous intra-epithelial lesions in women with HPV infection: an analysis of HPV types. DIANAIDS Collaborative Study Group. Int J Cancer 1997, 72:982-986.
9. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994, 170:1077-1085.
10. Cobo F., Concha A., Ortiz M. Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology. A correlation with histological study. Open Virol 2009, 3:60-66.
11. Garbuglia A.R., Carletti F., Minosse C., Piselli P., Zaniratti M.S., Serraino D., et al. Genetic variability in E6 and E7 genes of human papillomavirus -16, -18, -31 and -33 from HIV-1-positive women in Italy. New Microbiol 2007, 30:377-382.
12. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819.
13. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of Papillomaviruses. Virology 2004, 324:17-27.
14. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
15. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. Forum group members; Bethesda Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2001, 287:2140-2141.
16. Agarossi A., Ferrazzi E., Parazzini F., Perno C.F., Ghisoni L. Prevalence and type distribution of high-risk human Papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy. J Med Virol 2009, 81:529-535.
17. Rellihan M.A., Dooley D.P., Burke T.W., Berkland M.E., Longfield R.N. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol 1990, 36:435-438.
18. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500-1510.
19. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999, 91:226-236.
20. Luque A.E., Jabeen M., Messing S., Lane C.A., Demeter L.M., Rose R.C., et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J Infect Dis 2006, 194:428-434.
21. Verteramo R., Pierangeli A., Calzolari E., Patella A., Recine N., Mancini E., et al. Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect 2006, 8:2517-2521.
22. Chaturvedi A.K., Katki H.A., Hildesheim A., Rodríguez A.C., Quint W., Schiffman M., et al. CVT Group. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011, 203:910-920.
23. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000, 283:1031-1037.
24. Heard I., Potard V., Costagliola D. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Antivir Ther 2006, 11:1091-1096.
25. Rousseau M.C., Abrahamowicz M., Villa L.L., Costa M.C., Rohan T.E., Franco E.L. Predictors of cervical coinfection with multiple human Papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003 2003, 12:1029-1037.
26. Nielsen A., Kjaer S.K., Munk C., Iftner T. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis 2008, 35:276-282.
27. Ho G.Y., Bierman R., Beardsley L., Chang C.J., Burk R.D. Natural history of cervicovaginal Papillomavirus infection in young women. N Engl J Med 1998, 338:423-428.
28. Richardson H., Kelsall G., Tellier P., Voyer H., Abrahamowicz M., Ferenczy A., et al. The natural history of type-specific human Papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003, 12:485-490.
29. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital human Papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191:182-192.
30. Macleod I.J., O'Donnell B., Moyo S., Lockman S., Shapiro R.L., Kayembe M., et al. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana. J Med Virol 2011, 83:1689-1695.
31. Guess J.C., McCance D.J. Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human Papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production. J Virol 2005, 79:14852-14862.
32. Forslund O., Antonsson A., Nordin P., Stenquist B., Hansson B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999, 80:2437-2443.
33. Evans M.F., Adamson C.S., Schned L.M., St John T.L., Leiman G., Ashikaga T., et al. HPV is detectable in virtually all abnormal cervical cytology samples after reinvestigation of HPV negatives with multiple alternative PCR tests. Diagn Mol Pathol 2010, 19:144-150.
34. Mori S., Nakao S., Kukimoto I., Kusumoto-Matsuo R., Kondo K., Kanda T. Biased amplification of human papillomavirus DNA in specimens containing multiple human papillomavirus types by PCR with consensus primers. Cancer Sci 2011, 102:1223-1227.
35. Shen-Gunther J., Yu X. HPV molecular assays: defining analytical and clinical performance characteristics for cervical cytology specimens. Gynecol Oncol 2011, 123:263-271.
36. Millum J., Menikoff J. Streamlining ethical review. Ann Intern Med 2010, 153:655-657.